- Home
- MD vs CSTL Comparison
MD vs CSTL Comparison
Compare MD & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- CSTL
- Stock Information
- Founded
- MD 1979
- CSTL 2007
- Country
- MD United States
- CSTL United States
- Employees
- MD N/A
- CSTL N/A
- Industry
- MD Hospital/Nursing Management
- CSTL Medical Specialities
- Sector
- MD Health Care
- CSTL Health Care
- Exchange
- MD Nasdaq
- CSTL Nasdaq
- Market Cap
- MD 1.0B
- CSTL 848.1M
- IPO Year
- MD 1995
- CSTL 2019
- Fundamental
- Price
- MD $13.84
- CSTL $24.94
- Analyst Decision
- MD Buy
- CSTL Strong Buy
- Analyst Count
- MD 7
- CSTL 6
- Target Price
- MD $15.21
- CSTL $40.33
- AVG Volume (30 Days)
- MD 722.4K
- CSTL 434.0K
- Earning Date
- MD 02-20-2025
- CSTL 02-26-2025
- Dividend Yield
- MD N/A
- CSTL N/A
- EPS Growth
- MD N/A
- CSTL N/A
- EPS
- MD N/A
- CSTL 0.21
- Revenue
- MD $2,006,998,000.00
- CSTL $311,878,000.00
- Revenue This Year
- MD $3.13
- CSTL $51.29
- Revenue Next Year
- MD N/A
- CSTL N/A
- P/E Ratio
- MD N/A
- CSTL $118.55
- Revenue Growth
- MD N/A
- CSTL 62.43
- 52 Week Low
- MD $6.62
- CSTL $16.97
- 52 Week High
- MD $16.41
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- MD 53.44
- CSTL 36.58
- Support Level
- MD $13.57
- CSTL $23.95
- Resistance Level
- MD $14.10
- CSTL $26.52
- Average True Range (ATR)
- MD 0.41
- CSTL 2.08
- MACD
- MD 0.12
- CSTL -0.36
- Stochastic Oscillator
- MD 85.06
- CSTL 11.26
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.